Table 5.
POSIBA |
PULSE |
|||||||
---|---|---|---|---|---|---|---|---|
Multivariate S1 |
Multivariate S2 |
Multivariate S1 |
Multivariate S2 |
|||||
HR (95% CI) | P Value | HR (95% CI) | P Value | HR (95% CI) | P Value | HR (95% CI) | P Value | |
DP | 1.60 (0.96-2.67) | .072 | 1.72 (1.01-2.94) | .048 | 0.36 (0.19-0.69) | .0019 | 0.36 (0.19-0.69) | .0019 |
ECOG-PS >0 | 2.31 (1.56-3.43) | <.0001 | 2.49 (1.65-3.76) | <.0001 | 2.16 (1.10-4.25) | .026 | 2.16 (1.10-4.25) | .026 |
Age >65 years | ||||||||
BRAF mutated | 2.40 (1.38-4.17) | .0019 | 2.57 (1.47-4.49) | .0010 | 3.52 (1.32-9.35) | .012 | 3.52 (1.32-9.35) | .012 |
Surgery of primary tumor | 1.29 (0.88-1.90) | .19 | 0.33 (0.17-0.64) | .0013 | 0.33 (0.17-0.64) | .0013 | ||
Left-sided primary tumor | ||||||||
CEA (logarithmic term) | 0.50 (0.33-0.75) | .0008 | 0.50 (0.32-0.76) | .0014 | ||||
LDH (logarithmic term) | ||||||||
Liver metastasis | ||||||||
0 | ||||||||
<=3, <=5 cm | ||||||||
>3 or >5 cm |
CEA, carcinoembryonic antigen; CI, confidence interval; DP, double positivity; ECOG-PS, Eastern Cooperative Oncology Group performance status; HR, hazard ratio; LDH, lactate dehydrogenase; WT, wild-type.
S1: multivariate model including only the variables with a P value <.1 in the univariate analysis.
S2: multivariate model adjusted via automated stepwise selection of variables (see text for details).